CLX has gained 7.4% over the past week to $93.80, outpacing a peer median of 3.8%, yet short sellers have not retreated far enough to suggest the bear case is closing. Short interest in Clorox is now 8.74% of free float, roughly 10.66 million shares. That is down 4.3% on the week but up 19% over the past month, a net accumulation that persists even after the sharp pre-earnings…
CLX upgraded to In-Line by Evercore ISI, rating raised from Underperform; $99 target maintained as stock sits at $88.
Key data as of 11 Nov 2026
CLX upgraded to In-Line by Evercore ISI, rating raised from Underperform; $99 target maintained as stock sits at $88.
CLX short interest surges 26.6% in one week to 10% of free float, highest since early October.
5 Short Interest updates in 30 days
Why this matters: Evercore ISI upgraded CLX to In-Line this morning, breaking a run of downgrades from rival banks that had pushed the stock's short interest to its October highs. The upgrade lands the same day that…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CLX — free to start on ORTEX.
Sign up for free →Open CLX on ORTEX